Stater Bros Inactive 10-Q14 May 142013 Q2 Quarterly reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
Document and Entity Information	Mar. 30, 2014	13-May-14
Document Document And Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Mar-14	'
Document Fiscal Year Focus	'2013	'
Document Fiscal Period Focus	'Q2	'
Entity Registrant Name	'STATER BROS HOLDINGS INC	'
Entity Central Index Key	'0000882829	'
Current Fiscal Year End Date	'--09-28	'
Entity Filer Category	'Non-accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	31,863

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Mar. 30, 2014	Sep. 29, 2013
In Thousands, unless otherwise specified	Mar. 30, 2014	Sep. 29, 2013
Current assets	'	'
Cash and cash equivalents	$245,950	$242,818
Receivables, net of allowance of $975 and $1,106	37,626	36,080
Income tax receivable	0	1,413
Inventories	231,076	228,116
Prepaid expenses	15,965	14,570
Deferred income taxes, current portion	23,992	24,706
Note receivable, current portion	600	600
Total current assets	555,209	548,303
Property and equipment	'	'
Land	115,185	114,460
Buildings and improvements	615,381	606,112
Store fixtures and equipment	479,692	472,463
Property subject to capital leases	16,365	11,615
Total property and equipment (gross)	1,226,623	1,204,650
Less accumulated depreciation and amortization	628,351	604,631
Total property and equipment (net)	598,272	600,019
Deferred income taxes, less current portion	41,585	36,310
Deferred debt issuance costs, net	5,082	6,173
Note receivable, less current portion	215	616
Other assets	5,926	5,925
Total of deferred income taxes, deferred debt issuance cost and other assets	52,808	49,024
Total assets	1,206,289	1,197,346
Current liabilities	'	'
Accounts payable	137,617	144,214
Accrued payroll and related expenses	89,437	89,227
Accrued income taxes	5,882	0
Accrued interest	17,271	17,940
Other accrued liabilities	44,752	46,820
Current portion of capital lease obligations	1,538	772
Total current liabilities	368,833	323,783
Current portion of long-term debt	72,336	24,810
Long-term debt, less current portion	540,000	608,711
Capital lease obligations, less current portion	3,427	414
Long-term portion of self-insurance and other reserves	48,871	54,162
Long-term portion of deferred benefits	74,826	71,224
Accrued pension and other	26,675	25,602
Total liabilities	1,062,632	1,083,896
Commitments and contingencies	'	'
Stockholderâ€™s equity	'	'
Common Stock	0	0
Additional paid-in capital	8,270	8,270
Accumulated other comprehensive loss	-15,903	-15,903
Retained earnings	151,290	121,083
Total stockholderâ€™s equity	143,657	113,450
Total liabilities and stockholderâ€™s equity	1,206,289	1,197,346
Class A Common Stock [Member]	'	'
Stockholderâ€™s equity	'	'
Common Stock	$0	$0

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Mar. 30, 2014	Sep. 29, 2013
In Thousands, except Share data, unless otherwise specified	Mar. 30, 2014	Sep. 29, 2013
Allowance for receivables	$1,106	$975
Common Stock, par value (in dollars per share)	$0.01	$0.01
Common stock, shares authorized (in shares)	100,000	100,000
Common stock, shares issued (in shares)	0	0
Common stock, shares outstanding (in shares)	0	0
Class A Common Stock [Member]	'	'
Common Stock, par value (in dollars per share)	$0.01	$0.01
Common stock, shares authorized (in shares)	100,000	100,000
Common stock, shares issued (in shares)	32,521	32,521
Common stock, shares outstanding (in shares)	32,521	32,521

CONSOLIDATED_STATEMENTS_OF_INC

CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (USD $)	3 Months Ended		6 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 30, 2014	Mar. 31, 2013	Mar. 30, 2014	Mar. 31, 2013
Income Statement [Abstract]	'	'	'	'
Sales	$963,841	$961,896	$1,947,866	$1,930,640
Cost of goods sold	697,455	703,124	1,422,845	1,421,139
Gross profit	266,386	258,772	525,021	509,501
Operating expenses	'	'	'	'
Selling, general and administrative expenses	212,223	215,965	429,361	436,044
(Gain) loss on sale of assets	-1,451	6	-1,441	-1,927
Depreciation and amortization	11,859	11,566	23,232	23,249
Total operating expenses	222,631	227,537	451,152	457,366
Operating profit	43,755	31,235	73,869	52,135
Interest income	13	21	28	44
Interest expense	-11,470	-11,768	-22,956	-23,577
Income before income taxes	32,298	19,488	50,941	28,602
Income taxes	13,147	7,890	20,734	11,555
Net income and comprehensive income	$19,151	$11,598	$30,207	$17,047
Earnings per average common share outstanding	$588.88	$349.56	$928.85	$513.79
Average common shares outstanding	32,521	33,179	32,521	33,179

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Mar. 30, 2014	Mar. 31, 2013
Operating activities:	'	'
Net income	$30,207	$17,047
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation and amortization	28,758	28,951
Amortization of debt issuance costs	1,091	1,119
Increase in deferred income taxes	-4,561	-1,508
Gain on sale of assets	-1,441	-1,927
Changes in operating assets and liabilities:	'	'
Increase in receivables	-1,546	-5,815
Decrease in income tax receivables	1,413	6,513
Increase in inventories	-2,960	-3,071
Increase in prepaid expenses	-1,395	-1,610
Increase in other assets	-1	-28
Increase (decrease) in accounts payable	-6,597	1,394
Increase in income taxes payable	5,882	0
Decrease in other accrued liabilities	-2,527	-13,273
Increase (decrease) in long-term liabilities	-616	12,492
Net cash provided by operating activities	45,707	40,284
Investing activities:	'	'
Collections on note receivable	401	404
Purchase of property and equipment	-22,701	-13,500
Proceeds from sale of assets	1,881	3,209
Net cash used in investing activities	-20,419	-9,887
Financing Activities:	'	'
Principal payments on long-term debt	-21,185	-7,794
Principal payments on capital lease obligations	-971	-599
Dividends paid	0	-5,000
Net cash used in financing activities	-22,156	-13,393
Net increase in cash and cash equivalents	3,132	17,004
Cash and cash equivalents at beginning of period	242,818	219,800
Cash and cash equivalents at end of period	245,950	236,804
Interest paid	22,667	22,557
Income taxes paid	18,000	6,550
Capital lease additions	$4,750	$0

Basis_of_Presentation

Basis of Presentation	6 Months Ended
Basis of Presentation	Mar. 30, 2014
Text Block [Abstract]	'
Basis of Presentation	'
	Basis of Presentation
	The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the twenty-six weeks ended March 30, 2014 are not necessarily indicative of the results that may be experienced for the fiscal year ending September 28, 2014.
	The consolidated balance sheet at September 29, 2013 has been derived from the audited consolidated financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements.
	For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s report on Form 10-K for the fiscal year ended September 29, 2013.

Principles_of_Consolidation

Principles of Consolidation	6 Months Ended
Principles of Consolidation	Mar. 30, 2014
Text Block [Abstract]	'
Principles of Consolidation	'
	Principles of Consolidation
	The unaudited consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Stater Bros. Markets (“Markets”) and Stater Bros. Development, Inc. (“Development”), and Markets’ wholly-owned subsidiaries, Super Rx, Inc. (“Super Rx”) and SBM Dairies, Inc. (“Dairies”). All significant inter-company transactions have been eliminated in consolidation.

Use_of_Estimates

Use of Estimates	6 Months Ended
Use of Estimates	Mar. 30, 2014
Text Block [Abstract]	'
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

Income_Taxes

Income Taxes	6 Months Ended
Income Taxes	Mar. 30, 2014
Text Block [Abstract]	'
Income Taxes	'
	Income Taxes
	The Company establishes deferred tax liabilities for anticipated tax timing differences where payment of tax is anticipated. Such amounts represent a reasonable provision for taxes ultimately expected to be paid, and the amounts may be adjusted over time as additional information becomes known.
	The Company does not have any material tax positions that did not meet a “more-likely-than-not” recognition threshold. As such, the Company has not recorded any liabilities for uncertain tax positions. During the twenty-six weeks ended March 30, 2014, there were no material changes to the amount of uncertain tax positions.
	The Company recognizes interest and penalties related to income tax deficiencies or assessments by taxing authorities for any underpayment of income taxes separately from income tax expenses as either interest expense or other operating expenses.
	For federal and state tax purposes, the Company is subject to review of its fiscal 2010 through fiscal 2013 tax returns.

Retirement_Plans

Retirement Plans	6 Months Ended
	Mar. 30, 2014
Text Block [Abstract]	'
Retirement Plans	'
	Retirement Plans
	The Company has a Noncontributory Defined Benefit Pension Plan (the “Plan”) covering substantially all non-union employees. The Plan provides for benefits based on an employee’s compensation during the eligibility period while employed with the Company. The Company’s funding policy for the Plan is to contribute annually at a rate that is intended to provide sufficient assets to meet future benefit payment requirements. The Plan’s investments are recorded at fair value and include cash, which earns interest, governmental securities and corporate bonds and securities.
	The following table provides the components of net periodic pension expense:



		Thirteen Weeks Ended								Twenty-Six Weeks Ended

		Mar 31,				Mar 30,				Mar 31,			Mar 30,
		2013				2014				2013			2014
		(in thousands)
	Expected return on assets	$	(1,175	)		$	(1,325	)		$	(2,350	)	$	(2,658	)
	Service cost	1,223				872				2,445			1,908

	Interest cost	1,119				1,222				2,239			2,479

	Amortization of prior service cost	1				1				2			2

	Amortization of recognized losses	747				258				1,494			556

	Net pension expense	$	1,915			$	1,028			$	3,830		$	2,287



	Actuarial assumptions used to determine net pension expense were:
	Discount rate	3.7	%		4.7	%		3.7	%		4.7	%
	Rate of increase in compensation levels	3.08	%		3.08	%		3.08	%		3.08	%
	Expected long-term rate of return on assets	6	%		6	%		6	%		6	%

	The Company contributed approximately $1.0 million to the Plan in the twenty-six weeks ended March 30, 2014 and the Company expects to contribute an additional $3.0 million during the remainder of fiscal 2014.

Credit_Facility

Credit Facility	6 Months Ended
Credit Facility	Mar. 30, 2014
Text Block [Abstract]	'
Credit Facility	'
	Credit Facility
	On November 29, 2010, the Company and Markets entered into a $245.0 million senior secured credit facility (the “Credit Facility”) with Bank of America, N.A., as administrative agent and a lender. Lenders under the Credit Facility consist of a consortium of banks. The Credit Facility consists of a four-year $145.0 million term loan (the “Term Loan”) and a $100.0 million revolving credit facility (the “Revolving Credit Facility”). The Credit Facility is secured by substantially all of the Company’s personal property excluding certain intangible assets consisting of trademarks and shares of capital stock. The Credit Facility is guaranteed by the Company, its direct subsidiary Development and by its indirect subsidiaries Super Rx and Dairies.
	The Term Loan bears interest at the Eurodollar Rate plus 2.50% or the Base Rate plus 1.50% (as defined in the Credit Facility) and the interest under the Term Loan is payable quarterly in arrears and includes mandatory quarterly principal payments of 5.0%, of the original outstanding balance, in each of the first two years of the agreement and 10.0%, of the original outstanding balance, in each of the years three and four of the agreement. The Term Loan also includes additional mandatory principal payments on the Term Loan based on a percentage of “excess cash flow” as defined in the Credit Facility. The Term Loan is due November 29, 2014 with any remaining outstanding principal amounts under the Term Loan due as of that date. Accordingly, the Company has classified the entire $72.3 million outstanding on the Term Loan as of March 30, 2014 as current portion of long-term debt. The security held under the Credit Facility is held until the Term Loan is paid in full.
	During the twenty-six weeks ended March 30, 2014, the Company made principal payments on the Term Loan of approximately $21.2 million which consisted of a contractual quarterly principal payment of $10.9 million and an excess cash payment of $10.3 million.
	As of March 30, 2014, the interest rates on the Term Loan are based on the Eurodollar Rate and consisted of a 90 day rate of approximately 2.734% on approximately $7.2 million of outstanding principal amount and a 180 day rate of approximately 2.849% on approximately $65.1 million of outstanding principal amount.

	Note 6 – Credit Facility (contd.)
	Subject to certain restrictions, the entire amount of the Revolving Credit Facility may be used for loans, letters of credit or a combination thereof. Borrowing under the Revolving Credit Facility are secured and will be used for working capital, certain capital expenditures and other general corporate purposes. Letters of credit issued under the Revolving Credit Facility are expected to be used for workers’ compensation insurance obligations and may be used for new store construction and certain other corporate purposes. The availability of the loans and letters of credit are subject to certain borrowing restrictions.
	Loans under the Revolving Credit Facility bear interest at a rate based upon either (i) the “Base Rate” (defined as the higher of (a) the federal funds rate plus 0.50% and (b) the Bank of America “prime rate”), plus 1.50%, or (ii) the “Eurodollar Rate” (defined as the British Bankers Association LIBOR Rate adjusted for the maximum reserve requirement for Eurocurrency funding), plus 2.50%. For Eurodollar Rate loans, the Company will be entitled to select interest periods of one, two, three, six, nine or twelve months, subject to availability.
	The Credit Facility requires the Company and Markets to meet certain financial tests, including minimum net worth and the maintenance of minimum earnings levels. The Credit Facility contains covenants which, among other things, limit the ability of the Company and its subsidiaries to (i) incur indebtedness, grant liens and guarantee obligations, (ii) enter into mergers, consolidations, liquidations and dissolutions, asset sales, investments, leases and transactions with affiliates, (iii) make restricted payments and (iv) make certain amendments to the Indentures governing the $255.0 million 7.375% Senior Notes due November 15, 2018 (“7.375% Senior Notes”) and the $285.0 million 7.75% Senior Notes due April 15, 2015 (“7.75% Senior Notes”) (“Notes Indentures”). Markets and the Company’s other direct and indirect subsidiaries are not limited in their ability to transfer assets in the form of loans, advances or cash dividends to the Company.
	As of March 30, 2014, the Company and Markets were in compliance with all restrictive financial covenants under the Credit Facility.
	As of March 30, 2014, the Company had $62.7 million of outstanding letters of credit and had $37.3 million available under the Credit Facility.
	The Company had no borrowings outstanding under the Revolving Credit Facility as of March 30, 2014 and the Company did not incur any borrowings under the Revolving Credit Facility during the twenty-six weeks ended March 30, 2014.

Senior_Notes_and_Subsidiary_Gu

Senior Notes and Subsidiary Guarantee	6 Months Ended
Senior Notes and Subsidiary Guarantee	Mar. 30, 2014
Text Block [Abstract]	'
Senior Notes and Subsidiary Guarantee	'
	Senior Notes and Subsidiary Guarantee
	As of March 30, 2014, the Company had $285.0 million outstanding of the 7.75% Senior Notes and $255.0 million outstanding of the 7.375% Senior Notes, collectively (the “Notes”).
	The Notes are guaranteed by the Company’s subsidiaries Markets and Development and the Company’s indirect subsidiaries Super Rx and Dairies (each a “subsidiary guarantor”, and collectively, the “subsidiary guarantors”). Condensed consolidating financial information with respect to the subsidiary guarantors is not provided because the Company has no independent assets or operations, the subsidiary guarantees are full and unconditional and joint and several and there are no subsidiaries of the Company other than the subsidiary guarantors.

Refinancing

Refinancing	6 Months Ended
Refinancing	Mar. 30, 2014
Debt Disclosure [Abstract]	'
Refinancing	'
	Refinancing
	On May 12, 2014, the Company refinanced and signed a new Credit Agreement with Bank of America, N.A., as Administrative Agent, which consist of a five year Revolving Credit Facility in the amount of $150.0 million, a five year Term Loan A in the amount of $325.0 million and a seven year Term Loan B in the amount of $250.0 million (collectively the “Facility”). Loans under the new Revolving Credit Facility will bear an interest rate at the Eurodollar Rate plus 2.50%. The new Term Loan A will bear an interest rate at the Eurodollar Rate plus 2.50%. The Term Loan B will bear an interest rate at the Eurodollar Rate plus 3.75%, with a minimum Eurodollar Rate floor of 1.0%. Lending parties to the Facility consists of Bank of America, N.A., Merrill Lynch, Pierce, Fenner & Smith Incorporated and a consortium of other banks and institutional lenders. The Facility is secured by substantially all of the Company’s personal property excluding certain intangible assets consisting of trademarks and shares of the Company's capital stock. The Facility is guaranteed by the Company, its direct subsidiary Development and its indirect subsidiary Super RX. Covenants under the Facility will be similar to covenants under the Company’s old Revolving Credit Facility and Term Loan.

	The proceeds from the Facility and cash on hand will be used to pay-off the remaining outstanding $72.3 million of the Company’s existing Term Loan, the $285.0 million outstanding on the Company’s 7.75% Senior Notes due April 2015, the $255.0 million outstanding on the Company’s 7.375% Senior Notes due November 2018 and to pay fees and expenses from the transaction.

	On May 12, 2014, the Company issued irrevocable call notices to redeem its $285.0 million 7.75% Senior Notes and its $255.0 million 7.375% Senior Notes. The redemption on these notes will occur on June 11, 2014.

Litigation_Matters

Litigation Matters	6 Months Ended
Litigation Matters	Mar. 30, 2014
Text Block [Abstract]	'
Litigation Matters	'
	Litigation Matters
	In the ordinary course of business, the Company is party to various legal actions which it believes are incidental to the operation of its business and the business of its subsidiaries. The Company records an appropriate provision when the occurrence of loss is probable and can be reasonably estimated. The Company believes that the outcome of such legal proceedings to which it is currently a party will not have a material adverse effect upon its consolidated financial statements.

Dividends_and_Stock_Redemption

Dividends and Stock Redemption	6 Months Ended
Dividends and Stock Redemption	Mar. 30, 2014
Text Block [Abstract]	'
Dividends and Stock Redemption	'
	Dividends and Stock Redemption
	On December 27, 2012, the Company paid a $5.0 million dividend to La Cadena Investments (“La Cadena”), the sole shareholder of the Company. On April 15, 2014, the Company declared a $10.0 million dividend to La Cadena which was paid on April 17, 2014.
	On April 9, 2014, the Company redeemed 658 shares of its class A Common Stock for approximately $8.8 million. The redemption was for shares held by the two Trusts created under the Moseley Family Revocable Trust (the "MoseleyTrusts") which La Cadena had distributed to the Moseley Trusts prior to the redemption of the shares.
	As of March 30, 2014, and after taking into consideration the stock redemption on April 9, 2014 and the dividend payment on April 17, 2014, the Company had the ability and right to make restricted payments, including dividends, of $27.5 million.

Sale_of_Pharmacy_Prescription_

Sale of Pharmacy Prescription Files	6 Months Ended
Sale of Pharmacy Prescription Files	Mar. 30, 2014
Discontinued Operations and Disposal Groups [Abstract]	'
Sale of Pharmacy Prescription Files	'
	Sale of Pharmacy Prescription Files
	In the second quarter of fiscal 2014, the Company closed three under performing pharmacies and sold the prescription files associated with these closed pharmacies. It recognized a pre-tax gain from the sale of the prescription files of $1.2 million which has been recorded in gain on sale of assets the Consolidated Statements of Income and Comprehensive Income.

Fair_Value_of_Financial_Instru

Fair Value of Financial Instruments	6 Months Ended
Fair Value of Financial Instruments	Mar. 30, 2014
Text Block [Abstract]	'
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable to estimate that value:
	Cash and Cash Equivalents
	The carrying amount approximates fair value because of the short-term maturity of these instruments.
	Receivables
	The carrying amount approximates fair value because of the short-term maturity of these instruments.
	Note Receivable
	Although market quotes for the fair value of the Company’s note receivable are not readily available, the Company believes the stated value approximates fair value.
	Long-Term Debt
	The fair value of the 7.75% Senior Notes and the 7.375% Senior Notes are determined based on observable inputs that are corroborated by market data (Level 2 as defined by ASC Topic 820, “Fair Value Measurements and Disclosures”). Although market quotes for the fair value of the Company’s Term Loan are not readily available, the Company believes its stated value approximates fair value.
	As of March 30, 2014, the estimated fair value of the Company’s Long-Term Debt was $627.1 million.

Retirement_Plans_Tables

Retirement Plans (Tables)	6 Months Ended
	Mar. 30, 2014
Text Block [Abstract]	'
Components of Net Pension Expense and Periodic Benefit Costs	'
	The following table provides the components of net periodic pension expense:



		Thirteen Weeks Ended								Twenty-Six Weeks Ended

		Mar 31,				Mar 30,				Mar 31,			Mar 30,
		2013				2014				2013			2014
		(in thousands)
	Expected return on assets	$	(1,175	)		$	(1,325	)		$	(2,350	)	$	(2,658	)
	Service cost	1,223				872				2,445			1,908

	Interest cost	1,119				1,222				2,239			2,479

	Amortization of prior service cost	1				1				2			2

	Amortization of recognized losses	747				258				1,494			556

	Net pension expense	$	1,915			$	1,028			$	3,830		$	2,287

Actuarial Assumptions Used to Determine Net Pension Expense and Periodic Benefit Costs	'


	Actuarial assumptions used to determine net pension expense were:
	Discount rate	3.7	%		4.7	%		3.7	%		4.7	%
	Rate of increase in compensation levels	3.08	%		3.08	%		3.08	%		3.08	%
	Expected long-term rate of return on assets	6	%		6	%		6	%		6	%

Retirement_Plans_Components_of

Retirement Plans - Components of Net Pension Expense and Periodic Benefit Costs (Detail) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Mar. 30, 2014	Mar. 31, 2013	Mar. 30, 2014	Mar. 31, 2013
Disclosure Retirement Plans Components Of Net Pension Expense And Periodic Benefit Costs [Abstract]	'	'	'	'
Expected return on assets	($1,325)	($1,175)	($2,658)	($2,350)
Service cost	872	1,223	1,908	2,445
Interest cost	1,222	1,119	2,479	2,239
Amortization of prior service cost	1	1	2	2
Amortization of recognized losses	258	747	556	1,494
Net pension expense	$1,028	$1,915	$2,287	$3,830

Retirement_Plans_Actuarial_Ass

Retirement Plans - Actuarial Assumptions Used to Determine Net Pension Expense and Periodic Benefit Costs (Detail)	3 Months Ended		6 Months Ended
	Mar. 30, 2014	Mar. 31, 2013	Mar. 30, 2014	Mar. 31, 2013
Disclosure Retirement Plans Actuarial Assumptions Used To Determine Net Pension Expense And Periodic Benefit Costs [Abstract]	'	'	'	'
Discount rate	4.70%	3.70%	4.70%	3.70%
Rate of increase in compensation levels	3.08%	3.08%	3.08%	3.08%
Expected long-term rate of return on assets	6.00%	6.00%	6.00%	6.00%

Retirement_Plans_Additional_In

Retirement Plans - Additional Information (Detail) (USD $)	6 Months Ended
In Millions, unless otherwise specified	Mar. 30, 2014
Disclosure Retirement Plans Additional Information [Abstract]	'
Company contribution to defined benefit pension plan	$1
Company contribution to defined benefit pension plan, expected	$3

Credit_Facility_Additional_Inf

Credit Facility - Additional Information (Detail) (USD $)

Mar. 30, 2014

Sep. 29, 2013

Mar. 30, 2014

Nov. 29, 2010

Mar. 30, 2014

Nov. 29, 2010

Mar. 30, 2014

Nov. 29, 2010

Mar. 30, 2014

7.375% Senior Notes [Member]

7.75% Senior Notes [Member]

Credit Facility [Member]

Term Loan [Member]

Revolving Credit Facility [Member]

Eurodollar [Member]

Base Rate [Member]

90 day rate [Member]

12 month rate [Member]

Eurodollar [Member]

Federal Funds Rate [Member]

Prime Rate [Member]

Debt Instrument [Line Items]

Line of credit facility, amount

$245,000,000

Term loan maturity period

'4 years

Term loan, amount

145,000,000

Line of credit facility, amount

62,700,000

100,000,000

Quarterly principal payments percentage in years one and two

5.00%

Quarterly principal payments percentage in years three and four

10.00%

Current portion of long-term debt

72,336,000

24,810,000

Base rate

2.50%

1.50%

2.73%

2.85%

2.50%

0.50%

1.50%

Principal amount on interest loan

21,200,000

7,200,000

65,100,000

Contractual quarterly principal payment

10,900,000

Excess cash payment

10,300,000

Senior Notes, amount outstanding

255,000,000

285,000,000

Debt instrument, interest rate

7.38%

7.75%

Debt instrument, maturity date

15-Nov-18

15-Apr-15

Letters of credit available under the credit facility

$37,300,000

Senior_Notes_and_Subsidiary_Gu1

Senior Notes and Subsidiary Guarantee - Additional Information (Detail) (USD $)	Mar. 30, 2014
In Millions, unless otherwise specified	Mar. 30, 2014
7.75% Senior Notes [Member]	'
Debt Instrument [Line Items]	'
Senior Notes, amount outstanding	$285
Debt instrument, interest rate	7.75%
7.375% Senior Notes [Member]	'
Debt Instrument [Line Items]	'
Senior Notes, amount outstanding	$255
Debt instrument, interest rate	7.38%

Refinancing_Details

Refinancing (Details) (USD $)

Mar. 30, 2014

12-May-14

Jun. 11, 2014

7.75% Senior Notes [Member]

7.375% Senior Notes [Member]

Subsequent Event [Member]

Term Loan A [Member]

Term Loan B [Member]

7.75% Senior Notes [Member]

7.375% Senior Notes [Member]

Revolving Credit Facility [Member]

Forecast [Member]

Eurodollar [Member]

7.75% Senior Notes [Member]

7.375% Senior Notes [Member]

Debt Instrument [Line Items]

Term of the loan

'5 years

'7 years

'5 years

Debt Instrument, Face Amount

$325,000,000

$250,000,000

Revolving credit facility

150,000,000

Base rate

2.50%

3.75%

2.50%

Interest rate floor

1.00%

Repayment of debt

285,000,000

255,000,000

72,300,000

Debt instrument, interest rate

7.75%

7.38%

7.75%

7.38%

Redemption of senior notes

$285,000,000

$255,000,000

Dividends_and_Stock_Redemption1

Dividends and Stock Redemption - Additional Information (Detail) (USD $)	0 Months Ended		0 Months Ended
	Dec. 27, 2012	Mar. 30, 2014	Apr. 15, 2014	Apr. 17, 2014	Apr. 09, 2014
	Dec. 27, 2012	Mar. 30, 2014	Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]
Dividends Payable [Line Items]	'	'	'	'	'
Payments of dividends	$5,000,000	'	'	$10,000,000	'
Dividends Payable	'	'	10,000,000	'	'
Stock Redeemed or Called During Period, Shares	'	'	'	'	658
Stock Redeemed or Called During Period, Value	'	'	'	'	8,800,000
Restricted payments	'	$27,500,000	'	'	'

Sale_of_Pharmacy_Prescription_1

Sale of Pharmacy Prescription Files (Details) (Under Performing Pharmacies [Member], USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 30, 2014
	business_unit
Under Performing Pharmacies [Member]	'
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]	'
Number of business units sold	3
Gain on sale of prescription files	$1.20

Fair_Value_of_Financial_Instru1

Fair Value of Financial Instruments - Additional Information (Detail) (USD $)	Mar. 30, 2014
In Millions, unless otherwise specified	Mar. 30, 2014
Estimated Fair Value Of Financial Instruments [Line Items]	'
Fair value of Long-Term Debt	$627.10
7.75% Senior Notes [Member]	'
Estimated Fair Value Of Financial Instruments [Line Items]	'
Interest rate on Senior Notes	7.75%
7.375% Senior Notes [Member]	'
Estimated Fair Value Of Financial Instruments [Line Items]	'
Interest rate on Senior Notes	7.38%